Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1711 studies found for:    Open Studies | "Lymphatic Diseases"
Found 1711 studies with search of:   Open Studies | "Lymphatic Diseases"
Recognized Terms and Synonyms:
Lymphatic Diseases:   5886 studies
Disorder of lymphatics
Disorder of lymphoid system
Lymphangiopathy
disorders lymphatic system
lymphatic disorder
lymphatic system disorder
Related Terms:
Click on a related term to refine your search.
This will narrow your search by adding an additional search term.
If your search becomes too narrow (finds too few studies), broaden it by removing search terms with the Modify Search page.

A Acute Lymphoblastic Leukemia
B B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
C CD19
Cell
B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
T-cell Lymphoma
T-cell
T-cell Lymphoma
Chronic Lymphocytic Leukemia
CLL
cycle
Cyclophosphamide
D diffuse
Diffuse Large B-Cell Lymphoma
Disorders
Immunoproliferative Disorders
Lymphoproliferative Disorders
DLBCL
F follicular
free
H Histologic
Histologic Type
Neoplasms by Histologic Type
Hodgkin lymphoma
Non-Hodgkin's Lymphoma
I Ibrutinib
Immune
Immune System
Immune System Diseases
Immunoproliferative Disorders
L large
Diffuse Large B-Cell Lymphoma
Leukemia
Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphatic
Lymphatic Diseases
Lymphoblastic
Acute Lymphoblastic Leukemia
Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Lymphocytic
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphoid
Lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
T-cell Lymphoma
Hodgkin lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
T-cell Lymphoma
Lymphoproliferative Disorders
N Neoplasms
Neoplasms by Histologic Type
Non-Hodgkin's Lymphoma
O Overall
P Phase
R Refractory
Relapsed
response rate
Rituximab
S stem
survival
T T-cell
T-cell Lymphoma
V Vincristine